Veritec (VRTC) News Today $0.0051 0.00 (0.00%) As of 01/21/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Vertex Pharmaceuticals' SWOT analysis: stock outlook amid pipeline progressJanuary 21 at 9:59 PM | msn.comVertex Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy RatingJanuary 14, 2025 | markets.businessinsider.comVertex Therapeutics: The Pain Comes With The Territory For SuzetrigineJanuary 14, 2025 | seekingalpha.comCiti Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)January 13, 2025 | markets.businessinsider.comVertex Pharmaceuticals Earnings Preview: What to ExpectJanuary 9, 2025 | msn.comThose who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) three years ago are up 79%December 31, 2024 | finance.yahoo.comRBC Capital Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)December 24, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)December 24, 2024 | markets.businessinsider.comVertex wins approval for new once-daily CF drugDecember 24, 2024 | bizjournals.comBarclays Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)December 22, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Buy Rating Despite LSR Trial Setback, Future Prospects Remain StrongDecember 20, 2024 | markets.businessinsider.comVertex' Trikafta Gets Expanded FDA Approval For Cystic Fibrosis TreatmentDecember 20, 2024 | markets.businessinsider.comUS FDA approves Vertex Pharma's triple combo cystic fibrosis treatmentDecember 20, 2024 | reuters.comVertex's $10 Billion Blow: Painkiller Trial Results Spark Investor PanicDecember 20, 2024 | finance.yahoo.comVertex's non-opioid drug meets main goal in mid-stage nerve pain trialDecember 19, 2024 | reuters.com$100 Invested In This Stock 20 Years Ago Would Be Worth This Much TodayDecember 13, 2024 | benzinga.comVertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program ...December 8, 2024 | businesswire.comIs Vertex Pharmaceuticals Stock Underperforming the Dow?December 2, 2024 | msn.comIs Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?November 29, 2024 | msn.comVertex Pharmaceuticals (NASDAQ:VRTX) shareholders are still up 137% over 3 years despite pulling back 3.4% in the past weekNovember 25, 2024 | finance.yahoo.comGilead, Vertex initiated as new big biotech buys at CitiNovember 14, 2024 | msn.comVertex Pharmaceuticals price target raised to $408 from $361 at CanaccordNovember 6, 2024 | markets.businessinsider.comVertex Pharmaceuticals Inc (VRTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...November 6, 2024 | uk.finance.yahoo.comVertex Pharmaceuticals Tops Q3 EstimatesNovember 6, 2024 | fool.comVertex Pharmaceuticals: Promising Q3 Performance Amid Clinical and Regulatory UncertaintiesNovember 6, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects ItNovember 6, 2024 | seekingalpha.comVertex Pharmaceuticals (VRTX) Receives a Buy from Truist FinancialNovember 6, 2024 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | msn.comVertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strengthNovember 4, 2024 | reuters.comJim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?November 4, 2024 | benzinga.comVertex Pharmaceuticals (VRTX) Receives a Hold from ScotiabankOctober 28, 2024 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Gets a Buy from Truist FinancialOctober 28, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Hold Rating Amid Promising Developments and Pending Long-Term ValidationOctober 26, 2024 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISIOctober 24, 2024 | markets.businessinsider.com3 Pharma Stocks to Watch as Gene Therapy Gains MomentumOctober 23, 2024 | stocknews.comVertex Pharmaceuticals’ Promising Developments and Strategic Market Positioning Reinforce Buy RatingOctober 22, 2024 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)October 22, 2024 | markets.businessinsider.comWhat You Need to Know Ahead of Vertex Pharmaceuticals' Earnings ReleaseOctober 18, 2024 | msn.comPatients and providers want additional acute pain treatment optionsOctober 10, 2024 | usatoday.comVertex Joined The M&A Craze - Limited Upside Potential (Downgrade)October 10, 2024 | seekingalpha.comVertex Pharmaceuticals Inc (VRTX) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...October 9, 2024 | finance.yahoo.comWells Fargo tweaks signature picks list, sells AMZN, STZ while upping MSFTOctober 9, 2024 | seekingalpha.comIs Vertex Pharmaceuticals Incorporated (VRTX) Positioned for Continued Success in Cystic Fibrosis and Beyond?October 9, 2024 | uk.finance.yahoo.comBuy Rating Affirmed for Vertex Pharmaceuticals on Promising Pain Management Drug ProspectsOctober 8, 2024 | markets.businessinsider.comVertex Pharmaceuticals: Balancing Robust CF Market Presence with Regulatory Risks and Pipeline UncertaintiesOctober 4, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)October 4, 2024 | markets.businessinsider.comVertex Pharmaceuticals Hold Rating: Cautious Optimism and Risk-Reward Analysis Amidst LSR Trial AnticipationOctober 3, 2024 | markets.businessinsider.comReasons that Lifted Vertex Pharmaceuticals Incorporated (VRTX) in Q2October 3, 2024 | finance.yahoo.comVertex Says Health Canada Accepts NDS For Triple Combination To Treat Cystic FibrosisSeptember 26, 2024 | markets.businessinsider.comHealth Canada Oks Vertex's CASGEVY, First CRISPR/Cas9 Gene-Edited Therapy For Sickle Cell DiseaseSeptember 26, 2024 | markets.businessinsider.com Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTC Media Mentions By Week VRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTC News Sentiment▼0.470.63▲Average Computer and Technology News Sentiment VRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTC Articles This Week▼13▲VRTC Articles Average Week Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ucommune International News MetaWorks Platforms News Digital Locations News Haoxi Health Technology News Waitr News Cyber Apps World News China Networks International News U.S. Stem Cell News Environmental Service Professionals News Gopher Protocol News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VRTC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veritec, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veritec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTC Stock Alerts